Opendoor discusses the secret sauce: ‘A deeper mechanism to the world’
Opendoor, the seven-year-old startup that went public last December via merger with a special-purpose acquisition
Mechanism
Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria | News
CAMBRIDGE, Mass., March 24, 2021 /PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company